Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.527 USD | -0.55% | -15.77% | +3.45% |
May. 09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
Apr. 01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.45% | 63.81M | |
+5.05% | 109B | |
+10.94% | 105B | |
-0.38% | 22.25B | |
-11.83% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.85% | 16.85B | |
+3.84% | 13.76B | |
+34.83% | 12.46B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- JPMorgan Downgrades Atara Biotherapeutics to Neutral From Overweight; Price Target is $10